Although contrast-enhanced computed tomography (CT), dynamic magnetic resonance (MRI) and fine needle biopsy (FNB) are the standard of care to diagnose hepatocellular carcinoma (HCC), the clinical and economic benefits of the updated AASLD diagnostic algorithm, including the drop of contrast enhanced ultrasound (CEUS), have not been previously evaluated.
Manini, M., Sangiovanni, A., Fornari, F., Piscaglia, F., Biolato, M., Fanigliulo, L., Ravaldi, E., Grieco, A., Colombo, M., Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma, <<JOURNAL OF HEPATOLOGY>>, 2014; 60 (5): 995-1001. [doi:10.1016/j.jhep.2014.01.006] [http://hdl.handle.net/10807/61669]
Autori: | |
Titolo: | Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.jhep.2014.01.006 |
Data di pubblicazione: | 2014 |
Abstract: | Although contrast-enhanced computed tomography (CT), dynamic magnetic resonance (MRI) and fine needle biopsy (FNB) are the standard of care to diagnose hepatocellular carcinoma (HCC), the clinical and economic benefits of the updated AASLD diagnostic algorithm, including the drop of contrast enhanced ultrasound (CEUS), have not been previously evaluated. |
Lingua: | Inglese |
Rivista: | |
Citazione: | Manini, M., Sangiovanni, A., Fornari, F., Piscaglia, F., Biolato, M., Fanigliulo, L., Ravaldi, E., Grieco, A., Colombo, M., Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma, <<JOURNAL OF HEPATOLOGY>>, 2014; 60 (5): 995-1001. [doi:10.1016/j.jhep.2014.01.006] [http://hdl.handle.net/10807/61669] |
Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |